7 Recruiting Malignant Neoplasm Phase 2 Clinical Trials
Active phase 2 studies for malignant neoplasm enrolling across the USA. Verify eligibility and contact site coordinators.
All Malignant Neoplasm studiesPhase 2 Studies for Malignant Neoplasm
🔵 Active, Not Recruiting Phase2
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
📍 University of California at Los Angeles (UCLA ) — Los Angeles, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2
Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
📍 University of Iowa Hospitals ( Site 4017) — Iowa City, Iowa
View Study & Checklist ➔ 🟢 Recruiting Phase2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
📍 Clermont Oncology Center ( Site 0041) — Clermont, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
📍 Alaska Womens Cancer Care ( Site 0037) — Anchorage, Alaska
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
📍 Childrens Hospital Los Angeles ( Site 3006) — Los Angeles, California
View Study & Checklist ➔